Profile of adults with type 2 diabetes and uptake of clinical care best practices: results from the 2011 Survey on Living with Chronic Diseases in Canada - Diabetes component.

AIMS This study aimed to (1) describe the profile of adults with type 2 diabetes (T2D) in Canada and (2) assess the uptake of clinical care best practices, as defined by the Canadian Diabetes Association (CDA) Clinical Practice Guidelines (CPGs). METHODS We used data from the 2011 Survey on Living with Chronic Diseases in Canada - Diabetes component. Participants were aged 20 years and older, living in the 10 Canadian provinces, with self-reported T2D. Descriptive analyses present the prevalence of complications and comorbidities, as well as the level of clinical monitoring and self-monitoring/lifestyle management recommendations participants received. RESULTS We included 2335 participants with T2D, a mean age of 62.9 years, and high prevalence of complications/comorbidities and prescription medication use. Most participants reported being monitored as recommended for eye disease (73.9%), weight (81.0%), blood pressure (89.0%) and blood cholesterol levels (94.3%), but only 65.5% reported having at least two HbA1c tests during the last year and 46.5% reported an annual foot examination by a health professional. About two-thirds of the participants reported having received recommendations on weight management (59.9%) and physical activity (64.7%) from a health professional in the previous year; only 47.8% of the participants reported having received diet counseling to improve diabetes control. CONCLUSION Although the uptake of CDA CPGs for clinical and self-monitoring was high, with the majority of the participants reporting meeting most indicators, it was lower for HbA1c measurement and foot examination. Uptake of lifestyle management recommendations provided by health professionals was also significantly lower.

[1]  G. Worrall,et al.  Care of patients with type II diabetes: a study of family physicians' compliance with clinical practice guidelines. , 1997, The Journal of family practice.

[2]  Anke Richter,et al.  Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. , 2002, JAMA.

[3]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[4]  M. Stewart,et al.  Type 2 diabetes in family practice. Room for improvement. , 2003, Canadian family physician Medecin de famille canadien.

[5]  U. Linnenkamp,et al.  Global estimates of the prevalence of hyperglycaemia in pregnancy. , 2014, Diabetes research and clinical practice.

[6]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[7]  K F Rust,et al.  Variance estimation for complex surveys using replication techniques , 1996, Statistical methods in medical research.

[8]  Ping Zhang,et al.  The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention , 2012, Diabetes Care.

[9]  Lawrence A Leiter,et al.  Determinants of lifestyle behavior in type 2 diabetes: results of the 2011 cross-sectional survey on living with chronic diseases in Canada , 2013, BMC Public Health.

[10]  R. Kessels Patients’ Memory for Medical Information , 2003, Journal of the Royal Society of Medicine.

[11]  L. Welschen,et al.  Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. , 2012, The Cochrane database of systematic reviews.

[12]  C. Schoen,et al.  In chronic condition: experiences of patients with complex health care needs, in eight countries, 2008. , 2008, Health affairs.

[13]  Jonathan Krakoff,et al.  Four‐Year Weight Losses in the Look AHEAD Study: Factors Associated With Long‐Term Success , 2011, Obesity.

[14]  A. Kopp,et al.  The Relationship Between Financial Incentives and Quality of Diabetes Care in Ontario, Canada , 2012, Diabetes Care.

[15]  O. Pedersen,et al.  Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes , 2008, Diabetes Care.

[16]  Lawrence A Leiter,et al.  Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. , 2010, The Canadian journal of cardiology.

[17]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[18]  F. Burge,et al.  Drug management for hypertension in type 2 diabetes in family practice. , 2009, Canadian family physician Medecin de famille canadien.

[19]  L. McGuire,et al.  Remembering what the doctor said: organization and adults' memory for medical information. , 1996, Experimental aging research.

[20]  C. McCabe,et al.  Evaluation of a diabetic foot screening and protection programme , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[21]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[22]  Rena R Wing,et al.  Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. , 2010, Archives of internal medicine.

[23]  J. Dartigues,et al.  Effectiveness of disease-management programs for improving diabetes care: a meta-analysis , 2011, Canadian Medical Association Journal.

[24]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[25]  A Gray,et al.  Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. , 2009, Health technology assessment.

[26]  Marie-Dominique Beaulieu,et al.  Room for improvement: patients' experiences of primary care in Quebec before major reforms. , 2007, Canadian family physician Medecin de famille canadien.

[27]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[28]  S. Harris,et al.  Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). , 2005, Diabetes research and clinical practice.

[29]  Jason Gilmore,et al.  Diabetes-prevalence and care practices. , 2008, Health reports.